TheDoseReport Compares Semaglutide, Tirzepatide as GLP-1s Top $1,000 a Month
Updated
Updated · pluang.com · Jun 21
TheDoseReport Compares Semaglutide, Tirzepatide as GLP-1s Top $1,000 a Month
3 articles · Updated · pluang.com · Jun 21
Summary
TheDoseReport.com published a side-by-side review of semaglutide and tirzepatide, focusing on how much weight patients typically lose and what each drug costs.
Semaglutide delivers about 13.7% average weight loss, while the analysis says both GLP-1 treatments can cost more than $1,000 a month without insurance.
The comparison frames effectiveness and affordability as the key trade-off for people using the medications for weight management.
The report adds to growing consumer scrutiny of GLP-1 drugs as demand expands beyond diabetes treatment into obesity care.